LOCK Sleep Program for Dementia
(40Winks Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help nursing home residents with Alzheimer's disease or similar dementias improve their sleep using the LOCK Sleep Program. Researchers will first gather data on residents' sleep patterns, then introduce the intervention to assess its impact. The trial seeks to understand how to implement and maintain the program effectively. Nursing home residents identified by staff as having sleep problems may be a good fit for this study. As an unphased trial, this study offers participants the chance to contribute to valuable research that could enhance sleep quality for many others in the future.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the LOCK Sleep Program is safe for nursing home residents with dementia?
Research has shown that the LOCK Sleep Program aims to improve sleep quality for nursing home residents. This program relies on proven methods and emphasizes teamwork and observation by nursing home staff to help residents with dementia sleep better.
No specific safety issues or side effects have been reported for the LOCK Sleep Program. Since it involves training staff to better support residents' sleep, it is likely well-tolerated. The program does not introduce new medications or invasive procedures, which often carry more risks.
Overall, because the LOCK Sleep Program focuses on enhancing care practices rather than introducing new medical treatments, it is expected to be safe for participants.12345Why are researchers excited about this trial?
Researchers are excited about the LOCK Sleep Program for dementia because it offers a non-drug approach to improving sleep without the side effects associated with medications like melatonin or sedatives. This program stands out by using structured interventions over a ten-week period, followed by a sustainment phase, aiming to create lasting improvements in sleep patterns. By focusing on behavioral and environmental changes, the program may provide a safer alternative for managing sleep issues in dementia patients, potentially enhancing their overall quality of life.
What evidence suggests that the LOCK Sleep Program is effective for improving sleep in dementia patients?
Research has shown that the LOCK Sleep Program, available to participants in this trial, can improve sleep for nursing home residents with dementia. This program leverages the strengths of the nursing home staff and emphasizes teamwork. Studies have found that it helps staff effectively recognize and solve sleep problems. Consequently, residents experience better sleep, which can enhance their health and well-being. This proven method offers hope for improving the quality of life for this vulnerable group.12346
Who Is on the Research Team?
Lynn Snow, PhD
Principal Investigator
The University of Alabama
Are You a Good Fit for This Trial?
This trial is for nursing home residents aged 50 or older who have Alzheimer's disease or related dementias and are experiencing sleep problems, as identified by their caregivers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Control
Each nursing home serves as its own control. Control data will be collected for 1 week before the intervention begins.
Intervention
The intervention arm includes a ten-week active intervention phase using the LOCK-based sleep program.
Sustainment
A five-week sustainment phase to examine the sustainability of the LOCK sleep program.
Follow-up
Participants are monitored for safety and effectiveness after the intervention.
What Are the Treatments Tested in This Trial?
Interventions
- LOCK Sleep Program
- No intervention (control period/baseline data collection)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama, Tuscaloosa
Lead Sponsor
University of Massachusetts, Lowell
Collaborator
The University of Texas Health Science Center, Houston
Collaborator
University of Texas at Austin
Collaborator
Brown University
Collaborator